Bavarian Nordic Seeks Partner After RSV Jab Generates Glowing Phase II Data

Danish Biotech CEO Says Commercializing MVA-BN RSV Is Key Objective Now

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.